SCHEMBL7302272

SCHEMBL7302272

N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.50
GNPAT O15228 1/20 0.49
QRFPR Q96P65 1/20 0.49
NPY4R P50391 9/20 0.49
NPY5R Q15761 8/20 0.49
NPY1R P25929 7/20 0.49
NPY2R P49146 5/20 0.49
KISS1R Q969F8 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
PTPN2 P17706 1/20 0.45
PTPN1 P18031 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2750013 0.91 C3AR1 (0.50) FOLH1
SCHEMBL1694411 0.91 C3AR1 (0.50) FOLH1
SCHEMBL30294160 0.89 FOLH1 (0.45) FOLH1GNPATQRFPRNPY4RNPY5R
SCHEMBL30626300 0.87 OPRD1 (0.53) GNPATQRFPRNPY4RNPY5RNPY1R
SCHEMBL30692729 0.87 GNPAT (0.54) GNPATQRFPRNPY4RNPY5RNPY1R
SCHEMBL29447211 0.87 GNPAT (0.54) GNPATQRFPRNPY4RNPY5RNPY1R
SCHEMBL29590419 0.87 QRFPR (0.60) GNPATQRFPRNPY4RNPY5RNPY1R
SCHEMBL30692724 0.86 OPRD1 (0.53) GNPATNPY4RNPY5RNPY1RNPY2R
SCHEMBL10829274 0.86 PTGER4 (0.56) FOLH1GNPATQRFPRNPY4RNPY5R
SCHEMBL10829276 0.86 PTGER4 (0.56) FOLH1GNPATQRFPRNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1068586-C Crystalline, polymorphic form of (S,S,S)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl)tyrosine PFIZER RES & DEV CO N V S A (IE) 2001-07-18 CN disclosed
US-6180665-B1 HYPOTENSIVE AGENTS; ANGIOTENSIN CONVERTING ENZYME INHIBITOR PFIZER INC. 2001-01-30 US disclosed
EP-0731787-B1 CRYSTALLINE, POLYMORPHIC FORM OF (S,S,S)-N-(1-[2-CARBOXY-3-(N2-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE PFIZER LTD (GB) 1999-01-13 EP disclosed
CN-1142816-A Crystalline, polymorphic form of (S,S,S)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl)tyrosine PFIZER LTD (IE) 1997-02-12 CN disclosed
CN-1031051-C Cycloalkyl-substituted glutaramide antihypertensive agents PFIZER (US) 1996-02-21 CN disclosed
US-5362902-A Diuretics and treatment of cardiovascular disorders PFIZER INC. (US) 1994-11-08 US disclosed
EP-0358398-B1 CYCLOALKYL-SUBSTITUTED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS Pfizer Limited (GB) 1993-03-10 EP disclosed
US-5192800-A Hypotensive agents PFIZER INC. (US) 1993-03-09 US disclosed
CN-1016778-B spiro-substituted glutaric acid monoamides PFIZER LTD (GB) 1992-05-27 CN disclosed
EP-0274234-B1 SPIRO-SUBSITUTED GLUTARAMIDE DIURETIC AGENTS Pfizer Limited (GB) 1991-09-11 EP disclosed
US-5036104-A ENZYME INHIBITORS PFIZER INC. (US) 1991-07-30 US disclosed
US-5030654-A Glutaramide diuretic agents PFIZER INC. (US) 1991-07-09 US disclosed
US-4975444-A INHIBITORS OF ANGIORENSIN-CONVERTING ENZYME AS WELL AS A ENDOPEPTIDASE; CARDIOTONIC AGENTS; GLAUCOMA; DIURETICS PFIZER INC. (US) 1990-12-04 US disclosed
US-4960792-A HYPOTENSIVE AGENTS PFIZER INC. (US) 1990-10-02 US disclosed
WO-1990009374-A1 CYCLOALKYL-SUBSTITUTED GLUTARAMIDE DIURETIC AGENTS PFIZER LIMITED (GB) 1990-08-23 WO disclosed
CN-1040986-A The preparation of the glutaramide derivatives of cycloalkyl substituted PFIZER (US) 1990-04-04 CN disclosed
EP-0358398-A1 Cycloalkyl-substituted glutaramide antihypertensive agents Pfizer Limited (GB) 1990-03-14 EP disclosed
EP-0274234-A2 Spiro-subsituted glutaramide diuretic agents Pfizer Limited (GB) 1988-07-13 EP disclosed
CN-87107371-A The glutaramide diuretic agents of spiral shell-replacement 1988-07-06 CN disclosed